UC BON.CAP.CERT. 12/24 AMD/ DE000HD7ZMF3 /
12/11/2024 19:45:28 | Chg.-3.610 | Bid21:43:30 | Demandez à21:43:30 | Sous-jacent | Prix d'exercice | Date d'expiration | Type d'option |
---|---|---|---|---|---|---|---|
146.050EUR | -2.41% | 146.920 Bid taille: 500 |
146.940 Ask la taille: 500 |
ADVANCED MIC.DEV. D... | - - | 31/12/2024 | Call |
GlobeNewswire
01/09
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
GlobeNewswire
27/08
Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CL...
GlobeNewswire
27/08
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
GlobeNewswire
26/08
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal A...
GlobeNewswire
23/08
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular ...
- La première page
- Retour
- 1
- 2
- 3
- 4
- Suivant
- La dernière page